Cargando…
Mechanistic insights on novel small molecule allosteric activators of cGMP-dependent protein kinase PKG1α
cGMP-dependent protein kinase (PKG) represents a compelling drug target for treatment of cardiovascular diseases. PKG1 is the major effector of beneficial cGMP signaling which is involved in smooth muscle relaxation and vascular tone, inhibition of platelet aggregation and signaling that leads to ca...
Autores principales: | Tawa, Paul, Zhang, Lei, Metwally, Essam, Hou, Yan, McCoy, Mark A., Seganish, W. Michael, Zhang, Rumin, Frank, Emily, Sheth, Payal, Hanisak, Jennifer, Sondey, Christopher, Bauman, David, Soriano, Aileen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9425037/ https://www.ncbi.nlm.nih.gov/pubmed/35868561 http://dx.doi.org/10.1016/j.jbc.2022.102284 |
Ejemplares similares
-
The role of cGMP and PKG in cardioprotection
por: Downey, James M, et al.
Publicado: (2009) -
Role of cGMP/PKG in fat tissue
por: Pfeifer, Alexander
Publicado: (2011) -
Structures of human PKG reveal cGMP-selectived activation mechanisms
por: Huang, Gilbert Y, et al.
Publicado: (2013) -
Structural insights into selective small molecule activation of PKG1α
por: Metwally, Essam, et al.
Publicado: (2023) -
cGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathway
por: Park, Min, et al.
Publicado: (2018)